CareDx Activities at American Transplant Congress
The symposium’s agenda is as follows:
- Evolving role of molecular biomarkers in Banff criteria for diagnosis of acute antibody mediated rejection (ABMR)–
Mark Haas, M.D., Ph.D., Professor of Pathology; Senior Attending Pathologist – Cedars Sinai Comprehensive Transplant Center
- Introduction to AlloSure – donor-derived cell-free DNA (dd-cfDNA) – testing and implementation into clinical practice –
Alexander Wiseman, M.D., Professor of Medicine; Medical Director, Renal and Transplant Programs – University of Colorado
- New approaches in ABMR diagnosis and assessing responses to treatment of ABMR –
Stanley C. Jordan, M.D., Director, Division of Nephrology; Medical Director, Kidney Transplant Program; Medical Director, Human Leukocyte Antigen and Transplant Immunology Laboratory
- Clinical Experience using AlloSure for kidney transplant patients
a. Case Study –
Aleksandra De Golovine, M.D., Medical Director of Renal and Pancreas Transplantation; Assistant Professor of Medicine, Division of Nephrology– Memorial Hermann Hospital
b. Case Study –
Vinaya Rao, M.D., Professor, Medical Director, Kidney Transplant – Medical University of South Carolina
c. Case Study –
Kalathil Sureshkumar, M.D., Department of Medicine, Division of Nephrology and Hypertension– Allegheny General Hospital
d. Case Study –
Anup M. Patel, M.D. Transplant Clinical Director; Transplant Physician – Saint Barnabas Medical Center
Following the symposium, management
"We look forward to participating at the 2018
For more information, please visit: www.CareDx.com.
*This press conference is not part of the ATC official educational program
Chief Commercial Officer
Integrated Corporate Relations, Inc.
Source: CareDx, Inc.